Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome

Pediatric Infectious Disease Journal

Volumn 25, Issue 10, 2006, Pages 894-897

  Butthep, Punnee ^a   Chunhakan, Sirichan ^b   Tangnararatchakit, Kanchana ^b   Yoksan, Sutee ^b   Pattanapanyasat, Kovit ^b   Chuansumrit, Ampaiwan ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NONE

Author keywords

Circulating endothelial cells; Dengue hemorrhagic fever dengue shock syndrome; Soluble thrombomodulin

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CELL DAMAGE; CHILD; CONTROLLED STUDY; CONVALESCENCE; DENGUE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFECTION RISK; MALE; PREDICTION; PRIORITY JOURNAL;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD CELL COUNT; CHILD; CHILD, PRESCHOOL; DENGUE HEMORRHAGIC FEVER; DISEASE PROGRESSION; E-SELECTIN; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; RISK FACTORS; STATISTICS; STATISTICS AS TOPIC; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33749431835     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000237918.85330.b9     Document Type: Article

References (35)

1. Henchal EA, Putnak JR. The dengue virus. Clin Microbiol Rev. 1990;3:376-396.
2. Anonymous. Dengue Hemorrhagic Fever, Diagnosis, Treatment and Control. Geneva, Switzerland: World Health Organization; 1997.
3. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480-496.
4. Bhakdi S, Kazatchkine MD. Pathogenesis of dengue: an alternative hypothesis. Southeast Asian J Trop Med Public Health. 1990;21:652-657.
5. Halstead SB, Venkateshan CN, Gentry MK, et al. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol. 1984;132:1529-1532.
6. Anderson R, Wang S, Osiowy C, et al. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol. 1997;71:4226-4232.
7. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis. 1997;176:322-330.
8. Leitmeyer KC, Vaughn DW, Watts DM, et al. Dengue virus structural differences that correlate with pathogenesis. J Virol. 1999;73:4738-4747.
9. Diamond MS, Edgril D, Roberts TG, et al. Infection of human cells by dengue virus is modulated by different cell types viral strains. J Virol. 2000;74:7814-7823.
10. Monath TP. Dengue: the risk to developed and developing countries. Proc Natl Acad Sci USA. 1994;91:2395-2400.
11. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181:2-9.
12. Avirutnan P, Malasit P, Seliger B, et al. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol. 1998;161:6338-6346.
13. Green S, Vaughn DW, Kalayanarooj S, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis. 1999;179:755-762.
14. Libraty DH, Endy TP, Houng HSH, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis. 2002;185:1213-1221.
15. Maruyama I, Bell CE, Majerus PW. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol. 1985;101:363-371.
16. Ishii H, Salem HA, Bell CE, et al. Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain. Blood. 1986;67:362-365.
17. Hemmer CJ, Bierhaus A, Riedesel JV, et al. Elevated thrombomodulin plasma levels as a result of endothelial involvement in Plasmodium falciparum malaria. Thromb Haemost. 1994;72:457-464.
18. Ohnishi K, Kimura K. Serum thrombomodulin levels in patients with typhoid fever. Trans Roy Soc Trop Med Hyg. 1998;92:320-321.
19. Wada H, Ohiwa M, Kaneko T, et al. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol. 1992;39:20-24.
20. Takano S, Kimura S, Ohdama S, et al. Plasma thrombomodulin in health and diseases. Blood. 1990;76:2024-2029.
21. Butthep P, Bunyaratvej A, Funahara Y, et al. Alteration in vascular endothelial cell-related plasma proteins in thalassemic patients and their correlation with clinical symptoms. Thromb Haemost. 1995;74:1045-1049.
22. Koc M, Bihorac A, Segal MS. Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients. Am J Kidney Dis. 2003;42:704-712.
23. Butthep P, Rummavas S, Wisedpanichkij R, et al. Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia. Am J Hematol. 2002;70:100-106.
24. Solovey A, Lin Y, Browne P, et al. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med. 1997;337:1584-1590.
25. Beerepoot LV, Mehra N, Vermaat JSP, et al. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol. 2004;15:139-145.
26. Makin AJ, Blann AD, Chung NA, et al. Assessment of endothelial damage in atherosclerotic vascular disease by quantitation of circulating endothelial cells: relationship with von Willebrand factor and tissue factor. Eur Heart J. 2004;25:371-376.
27. Bull TM, Golpon H, Hebbel RP, et al. Circulating endothelial cells in pulmonary hypertension. Thromb Haemost. 2003;90:698-703.
28. Lin CF, Lei HY, Shiau AL, et al. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol. 2002;169:657-664.
29. Lin CF, Lei HY, Shiau AL, et al. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol. 2003;69:82-90.
30. Wills BA, Oragui EO, Stephens AC, et al. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis. 2002;35:277-285.
31. Remkova A, Kovacova E, Prikazska M, et al. Thrombomodulin as a marker of endothelium damage in some clinical conditions. Eur J Intern Med. 2000;11:79-84.
32. Bouvier CA, Gaynor E, Cintron JR, et al. Circulating endothelium as an indication of vascular injury. Thromb Diath Haemorrh. 1970;40:163.
33. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91:3527-3561.
34. Dignat-Gorge F, Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol. 2000;65:215-220.
35. Woywodt A, Bahlmann FH, Groot KD, et al. Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer. Nephrol Dial Transplant. 2002;17:1728-1730.